Literature DB >> 23302782

Role of TRPM2 in cell proliferation and susceptibility to oxidative stress.

Shu-jen Chen1, Wenyi Zhang, Qin Tong, Kathleen Conrad, Iwona Hirschler-Laszkiewicz, Michael Bayerl, Jason K Kim, Joseph Y Cheung, Barbara A Miller.   

Abstract

The transient receptor potential (TRP) channel TRPM2 is an ion channel that modulates cell survival. We report here that full-length (TRPM2-L) and short (TRPM2-S) isoform expression was significantly increased in human neuroblastoma compared with adrenal gland. To differentiate the roles of TRPM2-L and TRPM2-S in cell proliferation and survival, we established neuroblastoma SH-SY5Y cell lines stably expressing either TRPM2 isoform or empty vector. Cells expressing TRPM2-S showed significantly enhanced proliferation, downregulation of phosphatase and tensin homolog (PTEN), and increased protein kinase B (Akt) phosphorylation and cell surface glucose transporter 1 (Glut1) compared with cells expressing TRPM2-L or empty vector. ERK phosphorylation was increased, and forkhead box O 3a (FOXO3a) levels were decreased. Inhibitor studies demonstrated that enhanced proliferation was dependent on phosphatidylinositol 3-kinase/Akt, ERK, and NADPH oxidase activation. On the other hand, TRPM2-S-expressing cells were significantly more susceptible to cell death induced by low H2O2 concentrations (50-100 μM), whereas TRPM2-L-expressing cells were protected. This was associated with a significant increase in FOXO3a, MnSOD (SOD2), and membrane Glut1 in TRPM2-L-expressing cells compared with TRPM2-S expressing cells. We conclude that TRPM2 channels occupy a key role in cell proliferation and survival following oxidative stress in neuroblastoma. Our results suggest that overexpression of TRPM2-S results in increased proliferation through phosphatidylinositol 3-kinase/Akt and ERK pathways, while overexpression of TRPM2-L confers protection against oxidative stress-induced cell death through FOXO3a and SOD. TRPM2 channels may represent a novel future therapeutic target in diseases involving oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23302782      PMCID: PMC3671566          DOI: 10.1152/ajpcell.00069.2012

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  89 in total

1.  Intracellular calcium activates TRPM2 and its alternative spliced isoforms.

Authors:  Jianyang Du; Jia Xie; Lixia Yue
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-16       Impact factor: 11.205

Review 2.  The TRPC class of ion channels: a critical review of their roles in slow, sustained increases in intracellular Ca(2+) concentrations.

Authors:  Lutz Birnbaumer
Journal:  Annu Rev Pharmacol Toxicol       Date:  2009       Impact factor: 13.820

Review 3.  Mitochondria and calcium in health and disease.

Authors:  Michael R Duchen; Alexei Verkhratsky; Shmuel Muallem
Journal:  Cell Calcium       Date:  2008-04-18       Impact factor: 6.817

4.  Identification of novel sense and antisense transcription at the TRPM2 locus in cancer.

Authors:  Ugo Orfanelli; Ann-Kathrin Wenke; Claudio Doglioni; Vincenzo Russo; Anja Katrin Bosserhoff; Giovanni Lavorgna
Journal:  Cell Res       Date:  2008-11       Impact factor: 25.617

Review 5.  Role of H(2)O(2)-activated TRPM2 calcium channel in oxidant-induced endothelial injury.

Authors:  Claudie M Hecquet; Asrar B Malik
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

Review 6.  Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis.

Authors:  R Brooks Robey; Nissim Hay
Journal:  Semin Cancer Biol       Date:  2008-12-14       Impact factor: 15.707

7.  TRPM2-mediated Ca2+influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration.

Authors:  Shinichiro Yamamoto; Shunichi Shimizu; Shigeki Kiyonaka; Nobuaki Takahashi; Teruaki Wajima; Yuji Hara; Takaharu Negoro; Toshihito Hiroi; Yuji Kiuchi; Takaharu Okada; Shuji Kaneko; Ingo Lange; Andrea Fleig; Reinhold Penner; Miyuki Nishi; Hiroshi Takeshima; Yasuo Mori
Journal:  Nat Med       Date:  2008-06-08       Impact factor: 53.440

8.  Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis.

Authors:  Veronique Nogueira; Youngkyu Park; Chia-Chen Chen; Pei-Zhang Xu; Mei-Ling Chen; Ivana Tonic; Terry Unterman; Nissim Hay
Journal:  Cancer Cell       Date:  2008-12-09       Impact factor: 31.743

Review 9.  Understanding the Warburg effect: the metabolic requirements of cell proliferation.

Authors:  Matthew G Vander Heiden; Lewis C Cantley; Craig B Thompson
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

10.  PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability.

Authors:  Ana Silva; J Andrés Yunes; Bruno A Cardoso; Leila R Martins; Patrícia Y Jotta; Miguel Abecasis; Alexandre E Nowill; Nick R Leslie; Angelo A Cardoso; Joao T Barata
Journal:  J Clin Invest       Date:  2008-10-01       Impact factor: 14.808

View more
  25 in total

1.  A splice variant of the human ion channel TRPM2 modulates neuroblastoma tumor growth through hypoxia-inducible factor (HIF)-1/2α.

Authors:  Shu-jen Chen; Nicholas E Hoffman; Santhanam Shanmughapriya; Lei Bao; Kerry Keefer; Kathleen Conrad; Salim Merali; Yoshinori Takahashi; Thomas Abraham; Iwona Hirschler-Laszkiewicz; JuFang Wang; Xue-Qian Zhang; Jianliang Song; Carlos Barrero; Yuguang Shi; Yuka Imamura Kawasawa; Michael Bayerl; Tianyu Sun; Mustafa Barbour; Hong-Gang Wang; Muniswamy Madesh; Joseph Y Cheung; Barbara A Miller
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

Review 2.  Crosstalk between calcium and reactive oxygen species signaling in cancer.

Authors:  Nadine Hempel; Mohamed Trebak
Journal:  Cell Calcium       Date:  2017-01-18       Impact factor: 6.817

Review 3.  TRPM2 in Cancer.

Authors:  Barbara A Miller
Journal:  Cell Calcium       Date:  2019-03-06       Impact factor: 6.817

Review 4.  FoxO3a and disease progression.

Authors:  Richard Seonghun Nho; Polla Hergert
Journal:  World J Biol Chem       Date:  2014-08-26

5.  Activation of TRPM2 and TRPV1 Channels in Dorsal Root Ganglion by NADPH Oxidase and Protein Kinase C Molecular Pathways: a Patch Clamp Study.

Authors:  Mustafa Nazıroğlu
Journal:  J Mol Neurosci       Date:  2017-01-17       Impact factor: 3.444

Review 6.  Nitroxidative Signaling Mechanisms in Pathological Pain.

Authors:  Peter M Grace; Andrew D Gaudet; Vasiliki Staikopoulos; Steven F Maier; Mark R Hutchinson; Daniela Salvemini; Linda R Watkins
Journal:  Trends Neurosci       Date:  2016-11-12       Impact factor: 13.837

Review 7.  TRPM2 protects against tissue damage following oxidative stress and ischaemia-reperfusion.

Authors:  Barbara A Miller; Joseph Y Cheung
Journal:  J Physiol       Date:  2015-11-11       Impact factor: 5.182

8.  Trpm2 enhances physiological bioenergetics and protects against pathological oxidative cardiac injury: Role of Pyk2 phosphorylation.

Authors:  Barbara A Miller; JuFang Wang; Jianliang Song; Xue-Qian Zhang; Iwona Hirschler-Laszkiewicz; Santhanam Shanmughapriya; Dhanendra Tomar; Sudasan Rajan; Arthur M Feldman; Muniswamy Madesh; Shey-Shing Sheu; Joseph Y Cheung
Journal:  J Cell Physiol       Date:  2019-01-13       Impact factor: 6.384

9.  Depletion of the Human Ion Channel TRPM2 in Neuroblastoma Demonstrates Its Key Role in Cell Survival through Modulation of Mitochondrial Reactive Oxygen Species and Bioenergetics.

Authors:  Lei Bao; Shu-Jen Chen; Kathleen Conrad; Kerry Keefer; Thomas Abraham; John P Lee; JuFang Wang; Xue-Qian Zhang; Iwona Hirschler-Laszkiewicz; Hong-Gang Wang; Sinisa Dovat; Brian Gans; Muniswamy Madesh; Joseph Y Cheung; Barbara A Miller
Journal:  J Biol Chem       Date:  2016-09-30       Impact factor: 5.157

10.  Francisella tularensis Catalase Restricts Immune Function by Impairing TRPM2 Channel Activity.

Authors:  Nicole L Shakerley; Akshaya Chandrasekaran; Mohamed Trebak; Barbara A Miller; J Andrés Melendez
Journal:  J Biol Chem       Date:  2015-12-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.